Your browser doesn't support javascript.
loading
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.
Lozano, Elisa; Macias, Rocio I R; Monte, Maria J; Asensio, Maitane; Del Carmen, Sofia; Sanchez-Vicente, Laura; Alonso-Peña, Marta; Al-Abdulla, Ruba; Munoz-Garrido, Patricia; Satriano, Letizia; O'Rourke, Colm J; Banales, Jesus M; Avila, Matias A; Martinez-Chantar, Maria L; Andersen, Jesper B; Briz, Oscar; Marin, Jose J G.
Affiliation
  • Lozano E; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • Macias RIR; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Monte MJ; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • Asensio M; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Del Carmen S; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • Sanchez-Vicente L; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Alonso-Peña M; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • Al-Abdulla R; Salamanca University Hospital, IBSAL, University of Salamanca, Salamanca, Spain.
  • Munoz-Garrido P; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • Satriano L; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • O'Rourke CJ; Experimental Hepatology and Drug Targeting (HEVEFARM), IBSAL, University of Salamanca, Salamanca, Spain.
  • Banales JM; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Avila MA; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Martinez-Chantar ML; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Andersen JB; Department of Hepatology and Gastroenterology, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, San Sebastian, Spain.
  • Briz O; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
  • Marin JJG; Hepatology Programme, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain.
Hepatology ; 70(4): 1246-1261, 2019 10.
Article in En | MEDLINE | ID: mdl-30972782
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Bile Duct Neoplasms / Down-Regulation / Cholangiocarcinoma / Protein Kinase Inhibitors / Octamer Transcription Factor-1 / Sorafenib Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Language: En Journal: Hepatology Year: 2019 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Bile Duct Neoplasms / Down-Regulation / Cholangiocarcinoma / Protein Kinase Inhibitors / Octamer Transcription Factor-1 / Sorafenib Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Language: En Journal: Hepatology Year: 2019 Type: Article Affiliation country: Spain